Piramal Pharma Limited
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and manufacturing organisations (CDMO), (2) Complex hospital generics (critical care), and (3) consumer healthcare (OTC).Company entered Pharma space back in 1988 with acquisition of Nicholas Laboratories and grew through a series of Mergers & Acquisitionsand various organic…
What Piramal files
- Others47
- Investor Meet43
- Important30
- Updates25
- Board Meeting11
- PPTs8
Piramal Pharma Limited has announced a board meeting to review the integrated financial results for the quarter and nine months ended December 31, 2024. Key highlights include total income of ₹1,273.02 Cr and profit after tax of ₹118.80 Cr for the three months, compared to ₹210.06 Cr in the previous...
Piramal Pharma Limited reported its financial performance for the quarter and half-year ended September 30, 2024. Consolidated revenue experienced a robust year-over-year growth of 28.5%, reaching ₹1,037.09 crore, driven by increased demand and strategic market expansion efforts. The profit before tax was ₹35.38 crore, compared to a loss of ₹101.05...